CervoMed Inc.

CervoMed Inc. - Enterprise Valueverified

CRVO

Price:

$2.48

Market Cap:

$22.96M

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered...[Read more]

Industry

Biotechnology

IPO Date

2008-05-23

Stock Exchange

NASDAQ

Ticker

CRVO

The Enterprise Value as of July 2026 (TTM) for CervoMed Inc. (CRVO) is 15.02M

According to CervoMed Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.02M. This represents a change of -70.95% compared to the average of 51.70M of the last 4 quarters.

CervoMed Inc. (CRVO) Historical Enterprise Value (quarterly & annually)

How has CRVO Enterprise Value performed in the past?

The mean historical Enterprise Value of CervoMed Inc. over the last ten years is 13.35M. The current 15.02M Enterprise Value has changed 11.15% with respect to the historical average. Over the past ten years (40 quarters), CRVO's Enterprise Value was at its highest in in the June 2016 quarter at 818.61M. The Enterprise Value was at its lowest in in the December 2017 quarter at -8346468.00.

Quarterly (TTM)
Annual

Average

13.35M

Median

11.07M

Minimum

-10845316.00

Maximum

63.19M

CervoMed Inc. (CRVO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CervoMed Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 604.66%

Maximum Annual Enterprise Value = 63.19M

Minimum Annual Increase = -327.74%

Minimum Annual Enterprise Value = -10845316.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202563.19M538.89%
20249.89M-20.94%
202312.51M2.10%
202212.25M-274.00%
2021-7042058.00-128.51%
202024.70M-327.74%
2019-10845316.00604.66%
2018-1539094.50-124.27%
20176.34M-73.58%
201624.00M-5.68%

CervoMed Inc. (CRVO) Average Enterprise Value

How has CRVO Enterprise Value performed in the past?

The current Enterprise Value of CervoMed Inc. (CRVO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

28.53M

5-year avg

18.16M

10-year avg

13.35M

CervoMed Inc. (CRVO) Enterprise Value vs. Peers

How is CRVO’s Enterprise Value compared to its peers?

CervoMed Inc.’s Enterprise Value is less than Gain Therapeutics, Inc. (56.22M), less than Adagene Inc. (71.79M), greater than XBiotech Inc. (-46861605.00), less than OS Therapies Incorporated (66.34M), less than Nutriband Inc. (31.24M), less than Adicet Bio, Inc. (55.24M), less than NRx Pharmaceuticals, Inc. (50.05M), greater than Fortress Biotech, Inc. (-90930109.00), less than Lite Strategy, Inc. (24.82M), greater than vTv Therapeutics Inc. (-15696072.00),

CompanyEnterprise ValueMarket cap
56.22M$72.09M
71.79M$140.05M
-46861605.00$68.60M
66.34M$65.92M
31.24M$35.01M
55.24M$77.59M
50.05M$55.83M
-90930109.00$111.28M
24.82M$32.37M
-15696072.00$82.39M

Build a custom stock screener for CervoMed Inc. (CRVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CervoMed Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CervoMed Inc. (CRVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CervoMed Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is CervoMed Inc.'s Enterprise Value?

What is the highest Enterprise Value for CervoMed Inc. (CRVO)?

What is the 3-year average Enterprise Value for CervoMed Inc. (CRVO)?

What is the 5-year average Enterprise Value for CervoMed Inc. (CRVO)?

How does the current Enterprise Value for CervoMed Inc. (CRVO) compare to its historical average?